Common Stock and Stockholders' Equity (Tables)
|
6 Months Ended |
Jul. 31, 2026 |
| Equity [Abstract] |
|
| Summary of Shares of Common Stock Reserved for Future Issuance |
Shares of common stock reserved for future issuance as of the end of the period noted are as follows:
| | | | | | | July 31, 2026 | | Outstanding stock options and unvested RSUs and PSUs | 11,987,608 | | | Available for future stock option, RSU, and PSU grants | 24,298,651 | | | Available for Employee Stock Purchase Plan (“ESPP”) | 4,511,606 | | | Total common stock reserved for future issuance | 40,797,865 | |
|
| Summary of Restricted Stock Unit Activity |
A summary of the Company’s RSU activity and related information is as follows:
| | | | | | | | | | | | | Number of RSUs | | Weighted Average Grant Date Fair Value Per Share | | Outstanding at January 31, 2026 | 6,164,141 | | | $ | 19.01 | | | Granted | 4,787,544 | | | $ | 7.25 | | | Vested | (1,849,449) | | | $ | 18.96 | | | Forfeited or canceled | (854,785) | | | $ | 19.01 | | | Outstanding at July 31, 2026 | 8,247,451 | | | $ | 12.19 | |
|
| Summary of Restricted Stock Unit Activity |
A summary of the Company’s PSU activity and related information is as follows:
| | | | | | | | | | | | | Number of PSUs | | Weighted Average Grant Date Fair Value Per Share | | Outstanding at January 31, 2026 | 858,096 | | | $ | 19.09 | | Granted(1) | 487,333 | | | $ | 8.93 | | | Vested | (72,159) | | | $ | 21.62 | | | Forfeited or canceled | (37,055) | | | $ | 21.62 | | | Performance adjustment for 2025 PSU Awards | (640,646) | | | $ | 18.23 | | | Outstanding at July 31, 2026 | 595,569 | | | $ | 11.23 | | (1) This amount represents awards granted at 100% attainment. |
|
| Summary of Stock-based Compensation Expense |
Stock-based compensation expense included in the Company’s condensed consolidated statements of operations was as follows for the periods indicated (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended July 31, | | Six months ended July 31, | | 2026 | | 2025 | | 2026 | | 2025 | | Cost of revenue | $ | 665 | | | $ | 1,213 | | | $ | 1,514 | | | $ | 2,310 | | | Research and development | 5,592 | | | 9,560 | | | 11,729 | | | 19,400 | | | Sales and marketing | 3,064 | | | 5,285 | | | 7,248 | | | 11,504 | | | General and administrative | 7,151 | | | 9,902 | | | 13,944 | | | 18,499 | | Total stock-based compensation expense | $ | 16,472 | | | $ | 25,960 | | | $ | 34,435 | | | $ | 51,713 | |
|